Our gastroenterology product portfolio is not only dedicated to the advanced diagnosis of gut-related diseases such as inflammatory bowel disease or pancreatic insufficiency but also perfectly suited for the prevention of gut-related diseases such as colon cancer.

The ELISA tests are suited for single plate or medium-high-throughput analysis on automated readers. Below, you can find the markers and their diagnostic relevance at a glance.

Biomarkers for clinical diagnostics

Biological markers (biomarkers) are measurable indicators for specific conditions. The following biomarkers are relevant in gastroenterology:

  • Calprotectin is a highly specific indicator of gastrointestinal inflammation which is used for differentiation of IBD and IBS and for treatment monitoring.
  • Haemoglobin is a very efficient marker for colon cancer screening. The antibody-based tests RIDASCREEN® Haemoglobin and RIDASCREEN® Haemo-/Haptoglobin Complex are more specific than Guaiac-based tests. A combined testing of both parameters increases the probability to detect ademonas.
  • α1-antitrypsin and sIgA indicate the integrity of the gut wall. This is relevant for monitoring and diagnosing the leaky gut syndrome.
  • Pancreatic elastase and pankrin are used for the detection of pancreatic insufficiency and pancreatitis.

Therapeutic drug monitoring

Therapeutic drug monitoring of Infliximab (IFX, Remicade®) and Adalimumab (Humira®) supports the optimization of treatment and reduction of treatment costs.

Read more about therapeutic drug monitoring

Choose an indication

Choose a technology

You might also be interested in

ridascreen-anti-adm-antibodies
RIDASCREEN® Anti-ADM Antibo...
RIDASCREEN® Anti-ADM Antibodies is an enzyme linked immunoassay intended for the quantitative determination of antibodies to adalimumab (ATA) in hu...
rida-quick-ifx-monitoring
RIDA®QUICK IFX Monitoring
For in vitro diagnostic use. This test is an enzyme linked immunoassay intended for the quantitative determination of infliximab (IFX, Remicade®) a...
ridascreen_adm-monitoring
RIDASCREEN® ADM Monitoring
For in vitro diagnostic use. RIDASCREEN® ADM Monitoring is an enzyme immunoassay for the quantitative determination of adalimumab (ADM, Humira®) in...

Gastroenterology support

Questions? Tap into our team’s expertise. We’re here to support you and your business throughout the testing process to ensure your success

Start typing and press Enter to search